美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,221.13

-64.9523-5.05%

漲家數：- -

跌家數：7

平家數：- -

市盈率：- -

高：1,284.97

開：1,284.97

低：1,216.17

收：1,286.08

資料載入中...

BUZZ-Galderma 第一季度注射美容業績強勁，股價攀升

諾和諾德憑藉Wegovy大幅上調銷售指引的輝煌勢頭或近尾聲

羅氏：美國的投資計劃不會犧牲世界其他地區的利益

輝瑞4月23日成交額為11.45億美元

安進4月23日成交額為7.46億美元

Viking Therapeutics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要

Viking Therapeutics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要

市場消息：輝瑞公司在2025年美國臨牀腫瘤學會年會上提出癌症治療未來的大膽願景。

全球製藥巨頭起訴藥企仿製其減肥神藥

斯洛伐克總理暫停購買 COVID-19 疫苗，等待審查

碩迪生物盤中異動股價大漲5.03%報24.20美元

Viking Therapeutics, Inc.盤中異動早盤急速拉昇5.02%報26.76美元

諾和諾德盤中異動股價大漲3.66%

Altimmune, Inc.盤中異動急速拉昇5.57%

諾和諾德4月22日成交額為6.98億美元

安進4月22日成交額為5.77億美元

歐股“十一羅漢”收盤播報｜諾和諾德收跌超7.4%，歐萊雅則漲6.3%

碩迪生物盤中異動股價大跌5.37%

明晟公司MSCI北歐國家指數微幅下跌，報326.01點，北歐醫療保健板塊領跌。諾和諾德跌7.4%，在一眾成分股裏表現最差。

Viking Therapeutics, Inc.盤中異動快速上漲5.02%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1221.1315,"timestamp":1746561599999,"preClose":1286.0837,"halted":0,"volume":88725289,"delay":0,"changeRate":-0.050504,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-64.952271,"latestTime":"05-06 16:00:00 EDT","open":1284.9697,"high":1284.9697,"low":1216.1721,"amount":7842192696.324934,"amplitude":0.053494,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746624600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":10.034497,"peRate":33.640734,"turnoverRate":0.008399,"increases":0,"decrements":7,"flats":0,"marketCap":1308927154720,"floatMarketCap":1223500897312},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1284.9697,"amplitude":0.053494,"preClose":1286.0837,"low":1216.1721,"pbRate":"10.034497","latestPrice":1221.1315,"volume":88725289,"delay":0,"open":1284.9697,"prevYearClose":1305.0607,"prevWeekClose":1289.8245,"prevMonthClose":1353.2255,"prevQuarterClose":1314.3724,"fiveDayClose":1334.5167,"twentyDayClose":1172.5624,"sixtyDayClose":1418.3369,"secType":"PLATE","market":"US","turnoverRate":0.008399,"peRate":33.640734,"marketCap":1308927154720,"floatMarketCap":1223500897312,"timestamp":1746561599999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":0,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529625339","title":"BUZZ-Galderma 第一季度注射美容業績強勁，股價攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2529625339","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529625339?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 15:18","pubTimestamp":1745479131,"startTime":"0","endTime":"0","summary":"4月24日 -  ** Galderma GALD.S股价上涨 5.7%，该公司公布的第一季度财报  超过预期，主要原因是其注射美容部门的销售额增加。** 注射美容部门的销售额同比增长9.9%，Jefferies和J.P. Morgan的分析师指出，这比共识高出6%，主要是受到神经调节剂销售额的推动。** 美国销售额未达到一致预期，但国际销售额 \"令人愉悦的两位数 \"增长抵消了这一影响。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4T3R20KK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","LU0203201768.USD","LU2471134952.CNY","LU2552382132.HKD","SG9999017495.SGD","LU2362540622.SGD","SG9999018865.SGD","LU2602419157.SGD","LU0882574055.USD","LU1868836757.USD","LU2063271972.USD","LU2471134523.USD","LU1720051108.HKD","LU2461242641.AUD","LU2361044949.HKD","SG9999015986.USD","LU1291159041.SGD","LU0053666078.USD","SGXZ99366536.SGD","SG9999015945.SGD","LU0823416689.USD","LU1814569148.SGD","IE00BJT1NW94.SGD","LU1061106388.HKD","LU1069344957.HKD","SGXZ57979304.SGD","LU2211815571.USD","LU2468319806.SGD","LU1551013342.USD","LU1623119135.USD","SG9999018857.SGD","REGN","LU0672654240.SGD","LU0079474960.USD","LU0114720955.EUR","LU1548497426.USD","BK4599","LU0820561909.HKD","LU2362541273.HKD","BK4581","SG9999013999.USD","LU1712237335.SGD","IE00BJJMRZ35.SGD","BK4139","SG9999014898.SGD","LU2360106947.USD","LU0354030511.USD","LU1974910355.USD","LU0320765992.SGD"],"gpt_icon":1},{"id":"2529295436","title":"諾和諾德憑藉Wegovy大幅上調銷售指引的輝煌勢頭或近尾聲","url":"https://stock-news.laohu8.com/highlight/detail?id=2529295436","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529295436?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 14:59","pubTimestamp":1745477940,"startTime":"0","endTime":"0","summary":"自2021年推出广受欢迎的减肥药Wegovy以来，诺和诺德每年多次上调年度销售指引。诺和诺德2月曾表示，其已增加Wegovy在美国的供应以满足激增需求，并称指引已反映这一调整。诺和诺德及其竞争对手还面临产品被卷入美国总统特朗普发起的贸易战的风险。部分分析师预计，若美国食品药品监督管理局严格执行对仿制药的禁令，Wegovy和糖尿病药物Ozempic的处方量或会回升。诺和诺德称，该禁令可能将需求转向其正版产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424150139a464eda6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424150139a464eda6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BKVL7J92.USD","LU0154236417.USD","BK4585","LU1093756325.SGD","NVO","BK4532","BK4599","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007"],"gpt_icon":1},{"id":"2529964793","title":"羅氏：美國的投資計劃不會犧牲世界其他地區的利益","url":"https://stock-news.laohu8.com/highlight/detail?id=2529964793","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529964793?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 14:25","pubTimestamp":1745475927,"startTime":"0","endTime":"0","summary":"路透4月24日 - 罗氏公司ROG.S.首席执行官周四表示，该公司本周早些时候宣布在美国进行大规模投资，但这并不会以牺牲全球其他地区的预算为代价。这家瑞士制药商周二表示， ，未来五年将在美国投资 500 亿美元，创造超过 12,000 个新的就业机会，这是公司为应对特朗普总统的关税政策而进行的最新大规模投资。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nL4S3R20GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0354030511.USD","LU0708995401.HKD","LU2237443895.HKD","SGXZ31699556.SGD","LU1814569148.SGD","LU1057294990.SGD","LU2552382215.SGD","SG9999015952.SGD","LU1712237335.SGD","LU2237443549.SGD","LU0820561909.HKD","SG9999014880.SGD","LU0256863811.USD","LU0203202063.USD","SG9999017495.SGD","LU1917777945.USD","LU2471134796.USD","LU1868837300.USD","LU2237443382.USD","LU0456855351.SGD","LU2491050071.SGD","LU2468319806.SGD","BK4533","SGXZ99366536.SGD","LU0672654240.SGD","BK4599","LU0122379950.USD","LU1127390331.HKD","LU0109391861.USD","LU1366192091.USD","IE00BJLML261.HKD","SG9999014914.USD","IE00B2B36J28.USD","LU2023250504.SGD","LU1093756325.SGD","LU2089984988.USD","SG9999001176.SGD","LU1551013425.SGD","LU1548497426.USD","LU0079474960.USD","LU2237438978.USD","LU1035775433.USD","LU0096364046.USD","LU2471134879.HKD","LU0094547139.USD","LU0106261372.USD","SGXZ57979304.SGD","LU2357305700.SGD","LU1267930730.SGD"],"gpt_icon":1},{"id":"2529460611","title":"輝瑞4月23日成交額為11.45億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529460611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529460611?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 10:16","pubTimestamp":1745460984,"startTime":"0","endTime":"0","summary":"美东时间2025年4月23日，辉瑞成交额为11.45亿美元，成交额较昨日增加41.51%，当日成交量为5078.10万股。辉瑞于2025年4月23日跌0.62%，报22.39美元，该股过去5个交易日跌0.22%，年初至今跌14.21%，过去60日跌16.64%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-23|11.45亿|41.51%|5078.10万|#|2025-04-22|8.09亿|14.76%|3605.26万|#|2025-04-21|7.05亿|-41.56%|3202.10万|#|2025-04-17|12.06亿|44.24%|5407.37万|#|2025-04-16|8.36亿|-28.41%|3764.12万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424101630a464ab9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424101630a464ab9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","BK4599","LU0122379950.USD","IE00BBT3K403.USD","LU0306807586.USD","BK4585","LU0234572021.USD","BK4592","LU0321505868.SGD","LU0985481810.HKD","SG9999002232.USD","LU0170899867.USD","IE00B19Z3B42.SGD","LU1883839398.USD","SG9999011175.SGD","LU0456855351.SGD","LU1023059063.AUD","BK4588","LU0868494617.USD","SG9999001176.SGD","PFE","IE000M9KFDE8.USD","BK4581","IE00B19Z3581.USD","LU0225771236.USD","BK4533","LU0058720904.USD","BK4568","IE0002270589.USD","LU1057294990.SGD","BK4550","LU1894683264.USD","BK4534","SG9999002224.SGD","SG9999013999.USD","IE00BLSP4239.USD","LU1066053197.SGD","LU0321505439.SGD","LU0289739699.SGD","LU1894683348.USD","SG9999001176.USD","SGXZ57979304.SGD","SG9999003800.SGD","BK4007","LU0306806265.USD","LU1066051498.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2529697935","title":"安進4月23日成交額為7.46億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529697935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529697935?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 09:15","pubTimestamp":1745457352,"startTime":"0","endTime":"0","summary":"美东时间2025年4月23日，安进成交额为7.46亿美元，成交额较昨日增加29.32%，当日成交量为267.96万股。安进于2025年4月23日跌0.18%，报277.9美元，该股过去5个交易日跌5.89%，年初至今涨7.48%，过去60日跌0.99%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424091558a464995d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424091558a464995d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","SG9999001440.SGD","LU2089984988.USD","LU0320765992.SGD","LU0289739699.SGD","BK4581","BK4599","LU1057294990.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU0109394709.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","AMGN","LU0058720904.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU2242652126.USD","LU0868494617.USD","BK4588","BK4566","LU0889565916.HKD","LU1571399168.USD","LU0122379950.USD","BK4534","IE0002141913.USD","BK4139","BK4585","LU2468319806.SGD"],"gpt_icon":0},{"id":"2529916663","title":"Viking Therapeutics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2529916663","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529916663?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 04:38","pubTimestamp":1745440681,"startTime":"0","endTime":"0","summary":"Viking Therapeutics Inc 报告截至 3 月 31 日的季度业绩 - 收益摘要Viking Therapeutics Inc VKTX.OQ报告，截至3月31日的季度调整后每股亏损41美分，低于去年同期的每股收益-26美分。报告收入为零；分析师预期为零。Viking Therapeutics Inc 报告的季度每股收益为亏损 41 美分。该公司当季亏损 4563 万美元。Viking Therapeutics Inc 本季度股价上涨了 5.5%，今年迄今为止亏损了 36.7%。华尔街对 Viking Therapeutics Inc 的 12 个月目标价中位数为 102.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4S3R1218:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","VKTX","BK4599","BK4588"],"gpt_icon":0},{"id":"2529663915","title":"Viking Therapeutics Inc 報告截至 3 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663915","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663915?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 04:38","pubTimestamp":1745440681,"startTime":"0","endTime":"0","summary":"Viking Therapeutics Inc 报告截至 3 月 31 日的季度业绩 - 收益摘要Viking Therapeutics Inc VKTX.OQ报告，截至3月31日的季度调整后每股亏损41美分，低于去年同期的每股收益-26美分。Viking Therapeutics Inc 报告的季度每股收益为亏损 41 美分。该公司当季亏损 4563 万美元。Viking Therapeutics Inc 本季度股价上涨了 5.5%，今年迄今为止亏损了 36.7%。华尔街对 Viking Therapeutics Inc 的 12 个月目标价中位数为 102.00 美元。本摘要由 LSEG 4 月 23 日 08:37 p.m. UTC 调制解调器器生成。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4T3R1218:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4599","BK4588","VKTX"],"gpt_icon":0},{"id":"2529657721","title":"市場消息：輝瑞公司在2025年美國臨牀腫瘤學會年會上提出癌症治療未來的大膽願景。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529657721","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529657721?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 03:48","pubTimestamp":1745437717,"startTime":"0","endTime":"0","summary":"市场消息：辉瑞公司在2025年美国临床肿瘤学会年会上提出癌症治疗未来的大胆愿景。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/24034849811020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2529856665","title":"全球製藥巨頭起訴藥企仿製其減肥神藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2529856665","media":"壹点飞讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529856665?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 00:08","pubTimestamp":1745424508,"startTime":"0","endTime":"0","summary":"全球制药巨头礼来公司周三宣布，已对四家复合药厂提起法律诉讼，指控其非法生产并销售含有替尔泊肽的未经批准复合药物。这是继上月美国法官禁止药房仿制其减肥药和糖尿病药物后，礼来在知识产权保护方面挥出的又一记重拳。礼来制药向加州法院对他们提起诉讼，主要指控其销售含有添加剂或口服剂型的替尔泊肽仿制药品，且无法提供安全性和有效性的临床证据。根据美国FDA规定，在药物被列为短缺期间，复合药厂可以合法仿制相关药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424043139a6c59b2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424043139a6c59b2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868837136.USD","IE00BK4W5M84.HKD","LU0096364046.USD","LU0094547139.USD","LU0109391861.USD","BK4581","LU0471298694.HKD","LU1548497426.USD","LU1868837300.USD","LU0672654240.SGD","LU0354030511.USD","LU2089984988.USD","LU2112291526.USD","LU2471134952.CNY","LU2357305700.SGD","IE00B2B36J28.USD","LU0203202063.USD","LU1551013342.USD","SG9999015952.SGD","LU1988902786.USD","LU0289739699.SGD","LU0882574139.USD","LU0256863811.USD","LU2237443549.SGD","LLY","LU2265009873.SGD","LU1061106388.HKD","SG9999015978.USD","IE00BJT1NW94.SGD","SGXZ81514606.USD","LU2106854487.HKD","LU2602419157.SGD","LU0238689110.USD","IE0002141913.USD","BK4516","LU2237438978.USD","LU1267930730.SGD","LU0689472784.USD","BK4599","LU1291159041.SGD","SG9999017495.SGD","LU0456855351.SGD","LU0203201768.USD","SG9999014880.SGD","LU0256863902.USD","LU0198837287.USD","LU0882574055.USD","LU1280957306.USD","LU0079474960.USD","LU2361045086.USD"],"gpt_icon":1},{"id":"2529631052","title":"斯洛伐克總理暫停購買 COVID-19 疫苗，等待審查","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631052","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529631052?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 23:34","pubTimestamp":1745422499,"startTime":"0","endTime":"0","summary":"斯洛伐克总理暂停购买 COVID-19 疫苗，等待审查路透4月23日 - 斯洛伐克总理罗伯特-菲佐表示，斯洛伐克政府已于周三停止采购 COVID-19 疫苗，等待斯洛伐克科学院对其安全性进行审查。科特拉尔在没有证据的情况下声称基于 mRNA 技术的疫苗不安全，并呼吁政府停止接种。菲佐曾多次怀疑接种COVID-19疫苗的好处，并在大流行期间组织了一次违反封锁规定的抗议活动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4S3R11OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU1883839398.USD","LU0306807586.USD","LU1057294990.SGD","SG9999013999.USD","IE000M9KFDE8.USD","LU0122379950.USD","BK4550","BK4532","SG9999001176.SGD","IE00B19Z3B42.SGD","BK4551","LU0985481810.HKD","BK4585","LU1066051498.USD","MRNA","SG9999011175.SGD","BK4548","LU0058720904.USD","IE00B19Z3581.USD","LU0170899867.USD","BK4599","LU0225771236.USD","IE00BLSP4452.SGD","LU0225284248.USD","LU1023059063.AUD","SG9999003800.SGD","BK4501","IE0002270589.USD","BK4588","BK4533","LU1894683348.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0306806265.USD","BK4534","LU0868494617.USD","LU0456855351.SGD","BK4568","LU0234572021.USD","LU1894683264.USD","BK4581","BK4592","BK4007","SG9999002224.SGD","LU0289739699.SGD","LU1066053197.SGD","LU0321505439.SGD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2529268009","title":"碩迪生物盤中異動 股價大漲5.03%報24.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529268009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529268009?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 22:10","pubTimestamp":1745417434,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时10分，硕迪生物股票出现波动，股价大幅上涨5.03%。截至发稿，该股报24.20美元/股，成交量15.5897万股，换手率0.27%，振幅4.26%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.23亿美元，每股收益-2.33美元，毛利-2.60百万美元，市盈率-10.31倍。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221034aa2c78f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221034aa2c78f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2529638207","title":"Viking Therapeutics, Inc.盤中異動 早盤急速拉昇5.02%報26.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529638207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529638207?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:52","pubTimestamp":1745416324,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时52分，Viking Therapeutics, Inc.股票出现波动，股价急速拉升5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Instil Bio, Inc.涨幅较大，Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Ocean Biomedical, Inc.较为活跃，换手率分别为4635.83%、102.55%、28.99%，振幅较大的相关个股有Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Silexion Therapeutics Corp、Ensysce Biosciences, Inc.，振幅分别为101.45%、59.90%、52.94%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423215205aa2c78d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423215205aa2c78d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4007","VKTX","BK4599","LENZ","BK4588"],"gpt_icon":0},{"id":"2529631611","title":"諾和諾德盤中異動 股價大漲3.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529631611?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:33","pubTimestamp":1745415201,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时33分，诺和诺德股票出现异动，股价快速拉升3.66%。诺和诺德股票所在的制药行业中，整体涨幅为0.83%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。消息层面，截至21时33分，《减肥药双雄死磕口服新战场减肥药双雄死磕口服新战场》资讯为影响诺和诺德的重要信息。结果公布后，诺和诺德计划在2023年提交上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213321a463fa08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213321a463fa08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4585","LU0154236417.USD","BK4588","BK4599","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","LU1093756168.USD","BK4007"],"gpt_icon":1},{"id":"2529922689","title":"Altimmune, Inc.盤中異動 急速拉昇5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529922689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529922689?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 21:31","pubTimestamp":1745415072,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分，Altimmune, Inc.股票出现波动，股价大幅拉升5.57%。截至发稿，该股报5.12美元/股，成交量5.5037万股，换手率0.07%，振幅0.41%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213112a463f911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213112a463f911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"gpt_icon":0},{"id":"2529251860","title":"諾和諾德4月22日成交額為6.98億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529251860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529251860?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 10:11","pubTimestamp":1745374270,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日，诺和诺德成交额为6.98亿美元，成交额较昨日减少10.34%，当日成交量为1169.79万股。诺和诺德于2025年4月22日涨2.71%，报59.91美元，该股过去5个交易日跌9.31%，年初至今跌29.52%，过去60日跌31.08%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423101111a4633c6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423101111a4633c6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","BK4007","BK4599","LU1093756325.SGD","NVO","IE00BKVL7J92.USD","BK4585","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4532","BK4588"],"gpt_icon":1},{"id":"2529591552","title":"安進4月22日成交額為5.77億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529591552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529591552?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 09:15","pubTimestamp":1745370948,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日，安进成交额为5.77亿美元，成交额较昨日增加16.93%，当日成交量为208.10万股。安进于2025年4月22日涨1.72%，报278.4美元，该股过去5个交易日跌5.28%，年初至今涨7.68%，过去60日涨1.9%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091602a6c47862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091602a6c47862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","LU1061106388.HKD","BK4581","LU0320765992.SGD","LU2089984988.USD","LU1023059063.AUD","LU0058720904.USD","LU2468319806.SGD","LU2242652126.USD","SG9999001440.SGD","LU0289739699.SGD","BK4534","IE00BFTCPJ56.SGD","BK4139","BK4585","IE0002141913.USD","LU0122379950.USD","BK4566","LU2112291526.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","BK4533","LU1057294990.SGD","IE00B2B36J28.USD","BK4599","LU0889565916.HKD","LU0868494617.USD","LU0109394709.USD","LU2242646821.SGD","AMGN","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4588"],"gpt_icon":0},{"id":"2529213530","title":"歐股“十一羅漢”收盤播報｜諾和諾德收跌超7.4%，歐萊雅則漲6.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529213530","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529213530?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 01:35","pubTimestamp":1745343302,"startTime":"0","endTime":"0","summary":"周二，阿斯麦控股荷兰阿姆斯特丹股价收跌0.55%，报561.10欧元。诺和诺德哥本哈根股价收跌7.43%，报390.00，逼近2022年9月23日底部365.30，2024年6月26日还曾涨至1033.20创盘中历史最高。德国思爱普Sap收跌3.32%，雀巢跌1.5%，罗氏跌0.31%，诺华、阿斯利康、LVMH集团、赛诺菲则至多收涨0.5%，葛兰素史克张1.93%，欧莱雅涨6.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230136379740f1a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230136379740f1a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","LU1093756325.SGD","BK4007","LU0154236417.USD","BK4183","BK4585","BK4599","BK4588","LRLCY","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2529859539","title":"碩迪生物盤中異動 股價大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529859539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529859539?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 23:54","pubTimestamp":1745337275,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时54分，硕迪生物股票出现波动，股价快速下挫5.37%。截至发稿，该股报21.86美元/股，成交量52.9245万股，换手率0.92%，振幅5.80%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422235435a462a96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422235435a462a96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","GPCR","BK4007"],"gpt_icon":0},{"id":"2529721535","title":"明晟公司MSCI北歐國家指數微幅下跌，報326.01點，北歐醫療保健板塊領跌。諾和諾德跌7.4%，在一眾成分股裏表現最差。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529721535","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529721535?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 23:40","pubTimestamp":1745336434,"startTime":"0","endTime":"0","summary":"明晟公司MSCI北欧国家指数微幅下跌，报326.01点，北欧医疗保健板块领跌。诺和诺德跌7.4%，在一众成分股里表现最差。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22234049770680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0289960550.SGD","LU2210149790.SGD","BK4585","LU0109391861.USD","NVO","BK4588","LU2265009873.SGD","LU0175139822.USD","BK4112","LU0708995401.HKD","LU1093756168.USD","LU1804176565.USD","LU2095319765.USD","IE00BKVL7J92.USD","LU0289739343.SGD","LU1093756325.SGD","LU2210150020.SGD","BK4599","BK4007","LU0289961442.SGD","LU0320765059.SGD","MSCI","IE00BZ1G4Q59.USD","BK4532","LU1267930730.SGD","LU0154236417.USD","LU0511384066.AUD","LU0672654240.SGD"],"gpt_icon":0},{"id":"2529535074","title":"Viking Therapeutics, Inc.盤中異動 快速上漲5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529535074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529535074?lang=zh_tw&edition=fundamental","pubTime":"2025-04-22 23:32","pubTimestamp":1745335945,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时32分，Viking Therapeutics, Inc.股票出现异动，股价急速拉升5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233225a462a4e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233225a462a4e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","LENZ","VKTX","BK4585","BK4588","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":121,"code":"91000000","status":"200"}]}}